LYRICA 25 MG
PREGABALIN : 25 MG · DIN 02268418 · BGP PHARMA ULC
Health Canada status: MARKETED
What is LYRICA?
LYRICA 25 MG contains PREGABALIN : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02268418, held by BGP PHARMA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 11-May-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LYRICA used for?
LYRICA (pregabalin capsules) is indicated for the management of neuropathic pain associated with: Diabetic peripheral neuropathy; Postherpetic neuralgia; Spinal cord injury. LYRICA is indicated for the management of pain associated with fibromyalgia.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02268418 |
|---|---|
| Brand name | LYRICA |
| Generic / active ingredient | PREGABALIN : 25 MG |
| Manufacturer | BGP PHARMA ULC |
| Strength | 25 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N02BF02 PREGABALIN |
| AHFS class | 28:12.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-May-2023 |
| Original market date | 2005-07-18 00:00:00 |
How is it stored and handled?
null
How is it supplied?
HDPE bottles containing 60 capsules. The 25 mg and 75 mg capsules are also available in PVC/ aluminum blisters containing 14 capsules.
Is PREGABALIN in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N02BF02 PREGABALIN. 108 of 271 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-PREGABALIN | 150 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449870 |
| ACH-PREGABALIN | 225 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449897 |
| ACH-PREGABALIN | 25 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449838 |
| ACH-PREGABALIN | 300 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449900 |
| ACH-PREGABALIN | 50 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449846 |
| ACH-PREGABALIN | 75 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02449854 |
| AG-PREGABALIN | 150 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02480751 |
| AG-PREGABALIN | 25 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02480727 |
| AG-PREGABALIN | 300 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02480778 |
| AG-PREGABALIN | 50 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02480735 |
Who else supplies PREGABALIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PREGABALIN appears in 1034 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.